← Back to catalogue
IMPROSAFE® Blood Collection Set
EUDAMEDClass IIa (EU MDR)
Ref 596122300Model 21G × 3/4” × 12”; 22G × 3/4ʺ × 12ʺ; 23G × 3/4” × 12”; 24G × 3/4ʺ × 12ʺ; 25G × 3/4” × 12”; 21G × 3/4” × 7”; 22G × 3/4ʺ × 7ʺ; 23G × 3/4” × 7”; 24G × 3/4ʺ × 7ʺ; 25G × 3/4” × 7”
Identity
- Trade Name
- IMPROSAFE® Blood Collection Set EUDAMED
- Device Name
- IMPROSAFE® Blood Collection Set EUDAMED
- Model / Reference
- 21G × 3/4” × 12”; 22G × 3/4ʺ × 12ʺ; 23G × 3/4” × 12”; 24G × 3/4ʺ × 12ʺ; 25G × 3/4” × 12”; 21G × 3/4” × 7”; 22G × 3/4ʺ × 7ʺ; 23G × 3/4” × 7”; 24G × 3/4ʺ × 7ʺ; 25G × 3/4” × 7” EUDAMED596122300 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06974481831634 EUDAMED
- Basic UDI-DI
- 697448183001004UW EUDAMED
- EMDN Code
- A010199 NEEDLES FOR INFUSION AND COLLECTION - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Italy EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
IMPROSAFE® Blood Collection Set by Guangzhou Improve Medical Instruments Co., Ltd. — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 697448183001004UW | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Guangzhou Improve Medical Instruments Co., Ltd
- EUDAMED SRN
- CN-MF-000006536
- Authorised Representative
- Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001
Sources (1)
- EUDAMED 866f2ee0-b9d6-4fa9-9d9f-e257bb2cc9a8 61 fields · synced May 29, 2026